| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,552 |
12,350 |
$593K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,753 |
6,990 |
$461K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,315 |
2,291 |
$136K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,691 |
2,369 |
$87K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
787 |
785 |
$72K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
949 |
924 |
$36K |
| 17110 |
|
414 |
309 |
$27K |
| 94060 |
|
851 |
830 |
$22K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,837 |
1,676 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
565 |
517 |
$15K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,015 |
982 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
792 |
762 |
$12K |
| 94729 |
|
380 |
379 |
$11K |
| 99215 |
Prolong outpt/office vis |
121 |
108 |
$9K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
27 |
27 |
$9K |
| 94010 |
|
475 |
454 |
$6K |
| 94727 |
|
267 |
265 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
391 |
371 |
$4K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
835 |
778 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
268 |
257 |
$3K |
| 94726 |
|
84 |
79 |
$2K |
| 81002 |
|
766 |
735 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
74 |
73 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
460 |
445 |
$2K |
| 99441 |
|
118 |
100 |
$2K |
| 99406 |
|
228 |
205 |
$2K |
| 96127 |
|
337 |
322 |
$782.23 |
| 99201 |
|
30 |
30 |
$720.10 |
| 11102 |
|
12 |
12 |
$611.21 |
| 80053 |
Comprehensive metabolic panel |
129 |
126 |
$576.01 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
392 |
358 |
$530.15 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
54 |
54 |
$340.50 |
| 80061 |
Lipid panel |
46 |
46 |
$178.01 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
18 |
16 |
$171.78 |
| 99442 |
|
14 |
13 |
$154.50 |
| 90688 |
|
14 |
14 |
$140.04 |
| 87807 |
|
12 |
12 |
$120.22 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$81.90 |
| 88738 |
|
25 |
24 |
$24.96 |
| 3008F |
|
4,449 |
3,972 |
$0.00 |
| 1034F |
|
1,646 |
1,479 |
$0.00 |
| 3079F |
|
2,573 |
2,397 |
$0.00 |
| 1036F |
|
7,500 |
6,727 |
$0.00 |
| 3074F |
|
6,424 |
5,779 |
$0.00 |
| 3075F |
|
1,771 |
1,672 |
$0.00 |
| 3080F |
|
499 |
468 |
$0.00 |
| 3044F |
|
15 |
14 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
138 |
135 |
$0.00 |
| G8432 |
Depression screening not documented, reason not given |
41 |
38 |
$0.00 |
| G8433 |
Screening for depression not completed, documented patient or medical reason |
173 |
160 |
$0.00 |
| 1159F |
|
11,647 |
10,132 |
$0.00 |
| 3078F |
|
5,879 |
5,342 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
12,942 |
11,203 |
$0.00 |
| 3077F |
|
829 |
777 |
$0.00 |
| 1160F |
|
42 |
40 |
$0.00 |
| 3725F |
|
123 |
111 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
171 |
162 |
$0.00 |
| 99072 |
|
35 |
34 |
$0.00 |